Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
about
Guidelines for the use and interpretation of assays for monitoring autophagyCaloric restriction: is mammalian life extension linked to p53?The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cellsInterference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1β producing inflammasome.Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistanceCancer metabolism: current perspectives and future directions.Down-regulation of the autophagy gene, ATG7, protects bone marrow-derived mesenchymal stem cells from stressful conditions.Cancer and radiation therapy: current advances and future directions.The convergence of radiation and immunogenic cell death signaling pathways.Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells.TAK1 regulates autophagic cell death by suppressing the phosphorylation of p70 S6 kinase 1.Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells.Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies.Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch.Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.Role of autophagy in head and neck cancer and therapeutic resistance.Radiation pathology: from thorotrast to the future beyond radioresistance.Therapy-induced microenvironmental changes in cancer.Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistanceAnalysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance.2,2'-Methylenebis (6-tert-butyl 4-methylphenol) enhances the antitumor efficacy of belotecan, a derivative of camptothecin, by inducing autophagy.Simultaneous induction and blockade of autophagy by a single agent.
P2860
Q21996341-5EC18D43-DC1D-46C7-9B9E-645C2DF053A6Q26829232-652507D0-0B11-445C-8F2C-D79A0A599952Q33648709-53529693-74DA-4CD1-A49F-43584CCCC3E1Q33793750-20D3757F-3805-4FF2-A1C6-EEA9FDABAA84Q34421061-2CB128A9-A3B0-4191-8119-605652FF3CC0Q35713203-68162063-669B-4215-83FD-B66F463815E4Q35723836-296ECBCC-BA63-4C54-805F-F53350410287Q35800643-0156AF33-EB2C-4243-BC79-900B7AA48260Q35816527-AFE1B7EB-D3A0-4952-9DB5-BB3CA08E70E4Q36144356-C39BB8DB-9818-4367-9299-B1E380202F7EQ36412815-27C6068A-73B4-4C17-AC20-E4A84666461DQ36583648-44D9249F-F014-4E76-8AA6-8B0336BDC9FAQ36718933-27953F2A-C461-4E92-A3F8-BEC8688EF87CQ36723405-601715E7-A1F7-4613-887A-91840716CEB1Q37699466-1308CCD2-57DA-48B5-A8E8-F261F320477AQ37703384-5EA36464-031C-4DA7-8DE4-06BCCA83BF14Q38000992-D2D01072-2035-4C02-82A5-62E9871D9E46Q38180344-E0DF2123-72FF-4415-A327-29F44A44BD0AQ38209432-98F8F70E-985E-4ABE-B586-FA35DFBD0164Q38223241-9D90E574-E766-42ED-85D9-A4AD56EBD15FQ38756772-FBFB179B-7652-4915-91D5-78A4593FF076Q39809582-B8BC1059-885A-43DE-AF25-B9EA287C53C1Q42632659-D12DDA80-82C4-4993-951D-0B35369E9CF5Q48132579-C499C4CE-2C0A-4AC4-8717-50EA24494844Q49535292-A50CA443-9E3F-42DF-8D14-A7FC9388C657Q51766043-4F365F13-C8F8-4213-8F1F-9B7B5EE68515
P2860
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@ast
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@en
type
label
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@ast
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@en
prefLabel
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@ast
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@en
P2093
P2860
P356
P1476
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
@en
P2093
M Fukumoto
M H Roudkenar
Y Kuwahara
Y Uchiyama
P2860
P356
10.1038/CDDIS.2011.56
P577
2011-06-30T00:00:00Z